Jerome Powell Keeps Telling Us the Same Thing, But...
Is anyone else tired of financial pundits trying to parse Chairman Powell's statements to make whatever case they want to make? In my opinion, he's been clear than any Fed Chair since I started reading the Wall Street Journal as a teenager.
He said the following to Congress and has reiterated it over and over again in various iterations:
"Restoring price stability will likely require that we maintain a restrictive stance of monetary policy for some time. The historical record cautions strongly against prematurely loosening policy. We will stay the course until the job is done.”
They will follow the data. They will do what's necessary. They will bring inflation down to 2%. Personally, I feel good that we have a Fed that will do what's necessary to fulfil its mandate:
"The Federal Reserve System has been given a dual mandate—pursuing the economic goals of maximum employment and price stability"
When we are pivoting from loose to restrictive monetary policy, investors and CEOs of public companies should feel reassured that we have a Fed committed to accomplishing its goals.
Similar to my friend1 Jerome, I am always parroting the same advice to our Featured Companies and all public companies: focus on your long-term fundamental strategies, continue to improve your business and communicate your accomplishments effectively. This approach will "win" with the markets over time regardless of the current economic cycle.
Try as best you can to NOT obsess over your stock price. You will drive yourself crazy. Focus on the business. The best way to raise capital is to sell your product and generate sales. If you don't have a product then keep advancing towards commercialization. Build it well and investors will buy in when it's right for their own investment objectives.
At B2i Digital, we work with our "family" of Featured Companies who share this view and help them implement a consistent digital communication strategy with their key stakeholders. If you'd like to discuss this possibility for your company, email david@b2idigital.com
1 I am not actually friends with Jerome Powell, but he seems like the kind of guy that I'd enjoy having a drink with.
Our bags are packed to fly across the country on Saturday night to one of our favorite Featured Conferences hosted by ROTH MKM. Please let us know if you will be attending March 12 - 14 at the Ritz Carlton, Laguna Niguel in Dana Point, California.
(Nasdaq: AGRI) AgriFORCE is an agtech company focused on building an integrated agtech platform that combines the best technology, intellectual property and knowledge to solve an urgent problem – providing the best solutions to help drive sustainable crops and nutritious food for people around the world.
(Nasdaq: CCLD) CareCloud is a healthcare information technology company that offers comprehensive software and services to help medical groups increase revenue, streamline workflow, and modernize the patient experience. CareCloud offers the most diverse suite of software and services designed to help providers transform and improve their clinical, financial, and administrative operations.
(OTCQX: AGXXF, OSE: AGLX) Agilyx's proven, IP rich and commercially validated integrated chemical plastic waste recycling solution with feedstock management capability unlocks the circularity of plastic on a global scale. The company deploys an asset light model that enables fast scaling and leverages of first mover advantage in a massive yet un-tapped addressable market. Selected key partners are ExxonMobil & Virgin.
(Nasdaq: UNCY) Unicycive is a biotechnology company dedicated to developing treatments for certain medical conditions. Currently, two of their programs are focused on kidney disease that they believe have the potential to offer significant medical benefits. Their current development programs are focused on two novel therapies: Renazorb, for treatment of hyperphosphatemia in patients with chronic kidney disease, and UNI 494, for treatment of acute kidney injury.
(NYSEAMERICAN: AIM)AIM ImmunoTech is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19.
(Nasdaq: ALBT) Avalon GloboCare is a clinical-stage biotechnology company dedicated to develop and deliver innovative and transformative CellTech with multifunctional convergence in cellular technologies & therapeutics, precision diagnostics and intellectual property in the field of immuno-oncology and cellular medicines.
(OTCQB: NNMX) Nanōmix is a leader in decentralized testing and a participant in the large, fast-growing Point of Care (POC) diagnostics market. Their market-ready Critical Infection Panel is the only portable, rapid PCT assay that allows for obtaining critical information more quickly, leading to faster clinical decision-making.
(OTCQB: TGCB) Tego Cyber Inc. was created to capitalize on the emerging cyber threat intelligence market. They have developed a cyber threat intelligence application that integrates with leading security platforms to gather, analyze then identify threats to an enterprise network.
(OTCQB: AMMX) AmeraMex International Inc. sells, rents, and leases new and refurbished heavy equipment to a wide variety of industries, including construction, mining, infrastructure, logging, logistics, transportation, forestry conservation and commercial farming.
(Nasdaq: WISA) WiSA Technologies develops wireless audio integrated circuits for home entertainment and audio markets in the United States, Europe, and the Asia Pacific. WiSA believes that the future of audio technology is in wireless devices and that they are well positioned to deliver best-in-class immersive wireless sound technology.
(Nasdaq: TIVC) Tivic Health Systems is a commercial-phase health technology company developing and commercializing bioelectronic medicine to improve health, treat certain conditions and diseases, and make a meaningful difference in people's lives.
(Nasdaq: LUCY) Innovative Eyewear is the owner of the Lucyd brand of smart eyewear. Lucyd provides prescription smart frames direct-to-consumer and through retail distribution. Lucyd has 44 patents granted and pending and 11 trademarks, forming a growing IP position.
(Nasdaq: FWBI) First Wave BioPharma, Inc. is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases.
(Nasdaq: QNRX) Quoin Pharmaceuticals, Ltd. a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases.
(OTCQB: BICX) BioCorRx® is a leading-edge healthcare solutions company focused on improving the lives of those struggling with alcoholism, opioid abuse, as well as other addictive disorders.
New! B2i Digital is now a HubSpot Partner
Partnering with HubSpot is a natural extension of B2i Digital's mission to help public companies generate investor awareness through digital marketing. The HubSpot Marketing and CRM/Sales "Hubs" will allow our Featured Companies to optimize their marketing efforts and build a robust database of their investor contacts. The CMS/website Hub will allow them to capture investor data and efficiently update investor content on their site.
B2I DIGITAL, Inc. provides marketing support to the above mentioned conferences and their affiliated organizers ("Conferences"). B2I DIGITAL, Inc. is not an affiliate of the Conferences and is not authorized to represent or act on behalf of the Conferences, in any capacity. The Conferences have not reviewed and approved the content contained on the b2idigital.com website. Content about any specific company was provided and approved by that company. B2I DIGITAL, Inc. has not independently verified the accuracy of the information contained herein. No content contained herein shall be considered an offer to solicit the sale of any security.
Reach out anytime to discuss becoming a Featured Company, attending an upcoming conference, exploring how HubSpot can help scale your business or to over-analyze Fed commentary.
.png?upscale=true&width=1040&upscale=true&name=all-features-mar%20(1).png)
